1972
DOI: 10.1159/000192925
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Experiences with a New β-Sympathicomimetic Substance in the Provoked Attack in Occupational Asthma

Abstract: 18 untreated men with confirmed uncomplicated allergic bronchial asthma induced by flour were examined. In each patient, an attack of asthma was initially provoked by inhalatest tion and treated 40 min later. In a double-blind study, either 0.4 mg Th 1165a, the p-hydroxyphenyl derivative of orciprenaline, or an aerosol containing only propellant was used.The broncho-pulm’onary reaction was investigated by the technique of body plethysmography, the cardiovascular effects on the basis of the pulse rate and blood… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1976
1976
2008
2008

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 4 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…Other Medical Regimens Used During SICs: Studies have assessed the effect of medications on asthmatic responses and airway responsiveness induced by various occupational sensitizing agents (mainly diisocyanates and flour) during SICs in subjects with sensitizer-induced OA. [233][234][235][236][237] Although these data bring additional information on pathophysiology, they have a limited impact on the pharmacologic management of patients with sensitizer-induced OA.…”
Section: Other Antiinflammatory Agentsmentioning
confidence: 99%
“…Other Medical Regimens Used During SICs: Studies have assessed the effect of medications on asthmatic responses and airway responsiveness induced by various occupational sensitizing agents (mainly diisocyanates and flour) during SICs in subjects with sensitizer-induced OA. [233][234][235][236][237] Although these data bring additional information on pathophysiology, they have a limited impact on the pharmacologic management of patients with sensitizer-induced OA.…”
Section: Other Antiinflammatory Agentsmentioning
confidence: 99%